Mrs Molly Ann Rikhye, CRNP | |
10421 Oakland Sang Run Rd, Mc Henry, MD 21541-1526 | |
(301) 616-0207 | |
Not Available |
Full Name | Mrs Molly Ann Rikhye |
---|---|
Gender | Female |
Speciality | Clinical Nurse Specialist - Family Health |
Location | 10421 Oakland Sang Run Rd, Mc Henry, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1710377502 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
364SF0001X | Clinical Nurse Specialist - Family Health | R179800 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mrs Molly Ann Rikhye, CRNP 10421 Oakland Sang Run Rd, Mc Henry, MD 21541-1526 Ph: (301) 616-0207 | Mrs Molly Ann Rikhye, CRNP 10421 Oakland Sang Run Rd, Mc Henry, MD 21541-1526 Ph: (301) 616-0207 |
News Archive
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, and collaborators from the David H. Koch Institute for Integrative Research at the Massachusetts Institute of Technology (MIT) today announced the publication of new data in the journal Proceedings of the National Academy of Sciences (PNAS) describing further advancements in discovery and development of novel "lipidoid" formulations for the systemic delivery of RNAi therapeutics.
Biologists at Washington University in St. Louis have made major headway in explaining a mechanism by which plant cells silence potentially harmful genes.
A pioneering new system codeveloped by Sinai Hospital orthopedic surgeons Shawn Standard, M.D., head of Pediatric Orthopedics at the International Center for Limb Lengthening (ICLL), and John Herzenberg, M.D., director of the ICLL, offers a major advancement in limb lengthening surgery.
Rush University Medical Center in Chicago has been named a finalist for the American Hospital Association's Equity of Care Award for its efforts to reduce health care disparities and promote diversity within the organization's leadership and staff.
"I think the most special thing about our current time is the incredible opportunity that scientific advances have provided in the field of global health, giving us the ability to completely control highly dangerous infectious diseases such as AIDS, tuberculosis and malaria," Mark Dybul, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, writes in an opinion piece in the Huffington Post's "The Big Push" blog.
› Verified 6 days ago